Comparison of a step-down dose of once-daily ciclesonide with a continued dose of twice-daily fluticasone propionate in maintaining control of asthma

Author： Knox A   Langan J   Martinot J-B   Gruss C   Häfner D  

Publisher： Informa Healthcare

ISSN： 1473-4877

Source： Current Medical Research and Opinion, Vol.23, Iss.10, 2007-10, pp. : 2387-2394

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Once-Daily Administration of Fluticasone Propionate Does Not Worsen Controlled Airway Hyperresponsiveness in Patients with Asthma

By  

Respiration, Vol. 72, Iss. 5, 2005-09 ,pp. : 480-485

Karger

Access to resources Recommend Favorite

Conversion from twice‐daily to once‐daily tacrolimus formulation in pediatric liver transplant recipients – a long‐term prospective study

By  

TRANSPLANT INTERNATIONAL (ELECTRONIC), Vol. 31, Iss. 1, 2018-01 ,pp. : 38-44

John Wiley & Sons Inc

Access to resources Recommend Favorite

An observational study of fixed dose combination fluticasone propionate/salmeterol or fluticasone propionate alone on asthma-related outcomes**

By Stanford Richard H.   Fuhlbrigge Anne   Riedel Aylin   Rey Gabriel Gomez   Stempel David A.  

Current Medical Research and Opinion, Vol. 24, Iss. 11, 2008-11 ,pp. : 3141-3148

Informa Healthcare

Access to resources Recommend Favorite

The efficacy and safety of high-dose arbekacin sulfate therapy (once-daily treatment) in patients with MRSA infection

By Yamamoto Yoshihiro  

Journal of Infection and Chemotherapy, Vol. 18, Iss. 2, 2012-04 ,pp. : 241-246

Springer Publishing Company

Access to resources Recommend Favorite

Optimum Dose of Once‐Daily Oxybutynin Patch in Japanese Patients with Overactive Bladder: A Randomized Double‐Blind Trial Versus Placebo

By  

LUTS, Vol. 8, Iss. 3, 2016-09 ,pp. : 150-158

John Wiley & Sons Inc

Access to resources Recommend Favorite